FactorPad
Build a Better Process

Stock Risk Measures for Global Blood Therapeutics In

A quantitative factor review, as of September 30, 2020.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
by Paul Alan Davis, CFA
Updated: October 01, 2020
See how we arrive at an overall risk score of 60 for GBT below.

/ factorpad.com / stocks / f53szh.html


An ad-free and cookie-free webpage by FactorPad


GBT Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Global Blood Therapeutics In. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how GBT stock compares to 2,000+ US-based stocks, and to peers in the Health Technology sector and Biotechnology industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.

Identity

Sector and Industry

Share Data

Shares and Float

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f53szh.html


GBT stock risk
GLOBAL BLOOD THERAPEUTICS IN stock beta
GBT risk report
GBT f53szh
GBT risk analysis
GBT volatility
GLOBAL BLOOD THERAPEUTICS IN credit risk
GBT liquidity risk
GBT leverage
GBT valuation
GBT systematic risk
GBT specific risk
GLOBAL BLOOD THERAPEUTICS IN volatility
GBT analysis
GBT financial ratio

This is a new resource, spread the word, tell a friend